Indeed, human and animal studies confirmed that Reelin-expressing neurons are particularly vulnerable in AD.3 Thus, the discovery of the potential role of Reelin in contributing to neuronal vulnerability makes it an attractive target for therapeutic intervention. The gene discussed is RELN; the disease is Alzheimer disease.